APO Research
Talk to an analyst

APO RESEARCH · REPORT

Topical Analgesics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Topical Analgesics Market Outlook and Growth Opportunities 2026

22 December 2025196 pages

Choose your research edition.

Industry ResearchTopical Analgesics Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Topical Analgesics Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Topical Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Topical Analgesics Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Topical Analgesics Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Topical Analgesics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Topical Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Topical Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Topical Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Topical Analgesics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Topical Analgesics market include Sanofi, Johnson & Johnson, Novartis, Mylan, GSK, Topical BioMedics, THE PURE SOURCE, Teikoku Seiyaku and Qizheng, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Topical Analgesics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Topical Analgesics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Topical Analgesics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Topical Analgesics market size, projected growth trends, production technologies, key applications, and end-use industries.

Topical Analgesics Segment by Company

Sanofi

Johnson & Johnson

Novartis

Mylan

GSK

Topical BioMedics

THE PURE SOURCE

Teikoku Seiyaku

Qizheng

Mercury Healthcare

Lingrui

Huarun 999

Hisamitsu

Endo

Actavis

Topical Analgesics Segment by Type

Pain Relief Patches

Analgesic Creams

Analgesic Sprays

Topical Analgesics Segment by Application

Muscle Pain

Arthritis Pain

Topical Analgesics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Topical Analgesics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Topical Analgesics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Topical Analgesics significant trends, drivers, influence factors in global and regions.

6. To analyze Topical Analgesics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Topical Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Topical Analgesics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Topical Analgesics industry.

Chapter 3: Detailed analysis of Topical Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Topical Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Topical Analgesics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Topical Analgesics Industry Trends Table 2. Topical Analgesics Industry Drivers Table 3. Topical Analgesics Industry Opportunities and Challenges Table 4. Topical Analgesics Industry Restraints Table 5. Global Topical Analgesics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Topical Analgesics Revenue Share by Company (2021-2026) Table 7. Global Topical Analgesics Sales Volume by Company (k units) & (2021-2026) Table 8. Global Topical Analgesics Sales Volume Share by Company (2021-2026) Table 9. Global Topical Analgesics Average Price (US$/unit) of Company (2021-2026) Table 10. Global Topical Analgesics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Topical Analgesics Key Company Manufacturing Base & Headquarters Table 12. Global Topical Analgesics Company, Product Type & Application Table 13. Global Topical Analgesics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Topical Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Pain Relief Patches Table 18. Significant Companies of Analgesic Creams Table 19. Significant Companies of Analgesic Sprays Table 20. Global Topical Analgesics Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Topical Analgesics Sales Volume by Type (2021-2026) & (k units) Table 22. Global Topical Analgesics Sales Volume by Type (2027-2032) & (k units) Table 23. Global Topical Analgesics Sales Volume Share by Type (2021-2026) Table 24. Global Topical Analgesics Sales Volume Share by Type (2027-2032) Table 25. Global Topical Analgesics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Topical Analgesics Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Topical Analgesics Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Topical Analgesics Sales Value Share by Type (2021-2026) Table 29. Global Topical Analgesics Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Muscle Pain Table 31. Significant Companies of Arthritis Pain Table 32. Global Topical Analgesics Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Topical Analgesics Sales Volume by Application (2021-2026) & (k units) Table 34. Global Topical Analgesics Sales Volume by Application (2027-2032) & (k units) Table 35. Global Topical Analgesics Sales Volume Share by Application (2021-2026) Table 36. Global Topical Analgesics Sales Volume Share by Application (2027-2032) Table 37. Global Topical Analgesics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Topical Analgesics Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Topical Analgesics Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Topical Analgesics Sales Value Share by Application (2021-2026) Table 41. Global Topical Analgesics Sales Value Share by Application (2027-2032) Table 42. Global Topical Analgesics Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Topical Analgesics Sales by Region (2021-2026) & (k units) Table 44. Global Topical Analgesics Sales Market Share by Region (2021-2026) Table 45. Global Topical Analgesics Sales by Region (2027-2032) & (k units) Table 46. Global Topical Analgesics Sales Market Share by Region (2027-2032) Table 47. Global Topical Analgesics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Topical Analgesics Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Topical Analgesics Sales Value Share by Region (2021-2026) Table 50. Global Topical Analgesics Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Topical Analgesics Sales Value Share by Region (2027-2032) Table 52. Global Topical Analgesics Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Topical Analgesics Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Topical Analgesics Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Topical Analgesics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Topical Analgesics Sales by Country (2021-2026) & (k units) Table 57. Global Topical Analgesics Sales Market Share by Country (2021-2026) Table 58. Global Topical Analgesics Sales by Country (2027-2032) & (k units) Table 59. Global Topical Analgesics Sales Market Share by Country (2027-2032) Table 60. Global Topical Analgesics Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Topical Analgesics Sales Value Market Share by Country (2021-2026) Table 62. Global Topical Analgesics Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Topical Analgesics Sales Value Market Share by Country (2027-2032) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Topical Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Sanofi Topical Analgesics Product Portfolio Table 68. Sanofi Recent Development Table 69. Johnson & Johnson Company Information Table 70. Johnson & Johnson Business Overview Table 71. Johnson & Johnson Topical Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Johnson & Johnson Topical Analgesics Product Portfolio Table 73. Johnson & Johnson Recent Development Table 74. Novartis Company Information Table 75. Novartis Business Overview Table 76. Novartis Topical Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Novartis Topical Analgesics Product Portfolio Table 78. Novartis Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Topical Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Mylan Topical Analgesics Product Portfolio Table 83. Mylan Recent Development Table 84. GSK Company Information Table 85. GSK Business Overview Table 86. GSK Topical Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. GSK Topical Analgesics Product Portfolio Table 88. GSK Recent Development Table 89. Topical BioMedics Company Information Table 90. Topical BioMedics Business Overview Table 91. Topical BioMedics Topical Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Topical BioMedics Topical Analgesics Product Portfolio Table 93. Topical BioMedics Recent Development Table 94. THE PURE SOURCE Company Information Table 95. THE PURE SOURCE Business Overview Table 96. THE PURE SOURCE Topical Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. THE PURE SOURCE Topical Analgesics Product Portfolio Table 98. THE PURE SOURCE Recent Development Table 99. Teikoku Seiyaku Company Information Table 100. Teikoku Seiyaku Business Overview Table 101. Teikoku Seiyaku Topical Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Teikoku Seiyaku Topical Analgesics Product Portfolio Table 103. Teikoku Seiyaku Recent Development Table 104. Qizheng Company Information Table 105. Qizheng Business Overview Table 106. Qizheng Topical Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Qizheng Topical Analgesics Product Portfolio Table 108. Qizheng Recent Development Table 109. Mercury Healthcare Company Information Table 110. Mercury Healthcare Business Overview Table 111. Mercury Healthcare Topical Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Mercury Healthcare Topical Analgesics Product Portfolio Table 113. Mercury Healthcare Recent Development Table 114. Lingrui Company Information Table 115. Lingrui Business Overview Table 116. Lingrui Topical Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Lingrui Topical Analgesics Product Portfolio Table 118. Lingrui Recent Development Table 119. Huarun 999 Company Information Table 120. Huarun 999 Business Overview Table 121. Huarun 999 Topical Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Huarun 999 Topical Analgesics Product Portfolio Table 123. Huarun 999 Recent Development Table 124. Hisamitsu Company Information Table 125. Hisamitsu Business Overview Table 126. Hisamitsu Topical Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Hisamitsu Topical Analgesics Product Portfolio Table 128. Hisamitsu Recent Development Table 129. Endo Company Information Table 130. Endo Business Overview Table 131. Endo Topical Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Endo Topical Analgesics Product Portfolio Table 133. Endo Recent Development Table 134. Actavis Company Information Table 135. Actavis Business Overview Table 136. Actavis Topical Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Actavis Topical Analgesics Product Portfolio Table 138. Actavis Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Topical Analgesics Distributors List Table 142. Topical Analgesics Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Topical Analgesics Product Image Figure 2. Global Topical Analgesics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Topical Analgesics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Topical Analgesics Sales (2021-2032) & (k units) Figure 5. Global Topical Analgesics Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Topical Analgesics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Pain Relief Patches Image Figure 10. Analgesic Creams Image Figure 11. Analgesic Sprays Image Figure 12. Global Topical Analgesics Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Topical Analgesics Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Topical Analgesics Sales Volume Share by Type (2021-2032) Figure 15. Global Topical Analgesics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Topical Analgesics Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Topical Analgesics Sales Value Share by Type (2021-2032) Figure 18. Muscle Pain Image Figure 19. Arthritis Pain Image Figure 20. Global Topical Analgesics Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Topical Analgesics Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Topical Analgesics Sales Volume Share by Application (2021-2032) Figure 23. Global Topical Analgesics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Topical Analgesics Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Topical Analgesics Sales Value Share by Application (2021-2032) Figure 26. Global Topical Analgesics Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Topical Analgesics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Topical Analgesics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Topical Analgesics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Topical Analgesics Sales Value (2021-2032) & (US$ Million) Figure 31. North America Topical Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Topical Analgesics Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Topical Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Topical Analgesics Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Topical Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Topical Analgesics Sales Value (2021-2032) & (US$ Million) Figure 37. South America Topical Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Topical Analgesics Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Topical Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Topical Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Topical Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Topical Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Topical Analgesics Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Topical Analgesics Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Pain Relief Patches
  • Analgesic Creams
  • Analgesic Sprays
Applications
  • Muscle Pain
  • Arthritis Pain
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Mylan
  • GSK
  • Topical BioMedics
  • THE PURE SOURCE
  • Teikoku Seiyaku
  • Qizheng
  • Mercury Healthcare
  • Lingrui
  • Huarun 999
  • Hisamitsu
  • Endo
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Topical Analgesics Sales Value (2021-2032)
  4. 1.2.2 Global Topical Analgesics Sales Volume (2021-2032)
  5. 1.2.3 Global Topical Analgesics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Topical Analgesics Market Dynamics
  1. 2.1 Topical Analgesics Industry Trends
  2. 2.2 Topical Analgesics Industry Drivers
  3. 2.3 Topical Analgesics Industry Opportunities and Challenges
  4. 2.4 Topical Analgesics Industry Restraints
3 Topical Analgesics Market by Company
  1. 3.1 Global Topical Analgesics Company Revenue Ranking in 2025
  2. 3.2 Global Topical Analgesics Revenue by Company (2021-2026)
  3. 3.3 Global Topical Analgesics Sales Volume by Company (2021-2026)
  4. 3.4 Global Topical Analgesics Average Price by Company (2021-2026)
  5. 3.5 Global Topical Analgesics Company Ranking (2024-2026)
  6. 3.6 Global Topical Analgesics Company Manufacturing Base and Headquarters
  7. 3.7 Global Topical Analgesics Company Product Type and Application
  8. 3.8 Global Topical Analgesics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Topical Analgesics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Topical Analgesics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Topical Analgesics Market by Type
  1. 4.1 Topical Analgesics Type Introduction
  2. 4.1.1 Pain Relief Patches
  3. 4.1.2 Analgesic Creams
  4. 4.1.3 Analgesic Sprays
  5. 4.2 Global Topical Analgesics Sales Volume by Type
  6. 4.2.1 Global Topical Analgesics Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Topical Analgesics Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Topical Analgesics Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Topical Analgesics Sales Value by Type
  10. 4.3.1 Global Topical Analgesics Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Topical Analgesics Sales Value by Type (2021-2032)
  12. 4.3.3 Global Topical Analgesics Sales Value Share by Type (2021-2032)
5 Topical Analgesics Market by Application
  1. 5.1 Topical Analgesics Application Introduction
  2. 5.1.1 Muscle Pain
  3. 5.1.2 Arthritis Pain
  4. 5.2 Global Topical Analgesics Sales Volume by Application
  5. 5.2.1 Global Topical Analgesics Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Topical Analgesics Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Topical Analgesics Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Topical Analgesics Sales Value by Application
  9. 5.3.1 Global Topical Analgesics Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Topical Analgesics Sales Value by Application (2021-2032)
  11. 5.3.3 Global Topical Analgesics Sales Value Share by Application (2021-2032)
6 Topical Analgesics Regional Sales and Value Analysis
  1. 6.1 Global Topical Analgesics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Topical Analgesics Sales by Region (2021-2032)
  3. 6.2.1 Global Topical Analgesics Sales by Region: 2021-2026
  4. 6.2.2 Global Topical Analgesics Sales by Region (2027-2032)
  5. 6.3 Global Topical Analgesics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Topical Analgesics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Topical Analgesics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Topical Analgesics Sales Value by Region (2027-2032)
  9. 6.5 Global Topical Analgesics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Topical Analgesics Sales Value (2021-2032)
  12. 6.6.2 North America Topical Analgesics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Topical Analgesics Sales Value (2021-2032)
  15. 6.7.2 Europe Topical Analgesics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Topical Analgesics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Topical Analgesics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Topical Analgesics Sales Value (2021-2032)
  21. 6.9.2 South America Topical Analgesics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Topical Analgesics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Topical Analgesics Sales Value Share by Country, 2025 VS 2032
7 Topical Analgesics Country-level Sales and Value Analysis
  1. 7.1 Global Topical Analgesics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Topical Analgesics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Topical Analgesics Sales by Country (2021-2032)
  4. 7.3.1 Global Topical Analgesics Sales by Country (2021-2026)
  5. 7.3.2 Global Topical Analgesics Sales by Country (2027-2032)
  6. 7.4 Global Topical Analgesics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Topical Analgesics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Topical Analgesics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Topical Analgesics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Topical Analgesics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Topical Analgesics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Topical Analgesics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Topical Analgesics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Topical Analgesics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Topical Analgesics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Topical Analgesics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Topical Analgesics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Topical Analgesics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Topical Analgesics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Topical Analgesics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Topical Analgesics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Topical Analgesics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Topical Analgesics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Topical Analgesics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Topical Analgesics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Topical Analgesics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Topical Analgesics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Topical Analgesics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Topical Analgesics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Topical Analgesics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Topical Analgesics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Topical Analgesics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Topical Analgesics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Topical Analgesics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Topical Analgesics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Topical Analgesics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Topical Analgesics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Topical Analgesics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Topical Analgesics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Topical Analgesics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Topical Analgesics Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Topical Analgesics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Topical Analgesics Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Topical Analgesics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Topical Analgesics Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Topical Analgesics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Topical Analgesics Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 GSK
  26. 8.5.1 GSK Company Information
  27. 8.5.2 GSK Business Overview
  28. 8.5.3 GSK Topical Analgesics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 GSK Topical Analgesics Product Portfolio
  30. 8.5.5 GSK Recent Developments
  31. 8.6 Topical BioMedics
  32. 8.6.1 Topical BioMedics Company Information
  33. 8.6.2 Topical BioMedics Business Overview
  34. 8.6.3 Topical BioMedics Topical Analgesics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Topical BioMedics Topical Analgesics Product Portfolio
  36. 8.6.5 Topical BioMedics Recent Developments
  37. 8.7 THE PURE SOURCE
  38. 8.7.1 THE PURE SOURCE Company Information
  39. 8.7.2 THE PURE SOURCE Business Overview
  40. 8.7.3 THE PURE SOURCE Topical Analgesics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 THE PURE SOURCE Topical Analgesics Product Portfolio
  42. 8.7.5 THE PURE SOURCE Recent Developments
  43. 8.8 Teikoku Seiyaku
  44. 8.8.1 Teikoku Seiyaku Company Information
  45. 8.8.2 Teikoku Seiyaku Business Overview
  46. 8.8.3 Teikoku Seiyaku Topical Analgesics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Teikoku Seiyaku Topical Analgesics Product Portfolio
  48. 8.8.5 Teikoku Seiyaku Recent Developments
  49. 8.9 Qizheng
  50. 8.9.1 Qizheng Company Information
  51. 8.9.2 Qizheng Business Overview
  52. 8.9.3 Qizheng Topical Analgesics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Qizheng Topical Analgesics Product Portfolio
  54. 8.9.5 Qizheng Recent Developments
  55. 8.10 Mercury Healthcare
  56. 8.10.1 Mercury Healthcare Company Information
  57. 8.10.2 Mercury Healthcare Business Overview
  58. 8.10.3 Mercury Healthcare Topical Analgesics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Mercury Healthcare Topical Analgesics Product Portfolio
  60. 8.10.5 Mercury Healthcare Recent Developments
  61. 8.11 Lingrui
  62. 8.11.1 Lingrui Company Information
  63. 8.11.2 Lingrui Business Overview
  64. 8.11.3 Lingrui Topical Analgesics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Lingrui Topical Analgesics Product Portfolio
  66. 8.11.5 Lingrui Recent Developments
  67. 8.12 Huarun 999
  68. 8.12.1 Huarun 999 Company Information
  69. 8.12.2 Huarun 999 Business Overview
  70. 8.12.3 Huarun 999 Topical Analgesics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Huarun 999 Topical Analgesics Product Portfolio
  72. 8.12.5 Huarun 999 Recent Developments
  73. 8.13 Hisamitsu
  74. 8.13.1 Hisamitsu Company Information
  75. 8.13.2 Hisamitsu Business Overview
  76. 8.13.3 Hisamitsu Topical Analgesics Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hisamitsu Topical Analgesics Product Portfolio
  78. 8.13.5 Hisamitsu Recent Developments
  79. 8.14 Endo
  80. 8.14.1 Endo Company Information
  81. 8.14.2 Endo Business Overview
  82. 8.14.3 Endo Topical Analgesics Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Endo Topical Analgesics Product Portfolio
  84. 8.14.5 Endo Recent Developments
  85. 8.15 Actavis
  86. 8.15.1 Actavis Company Information
  87. 8.15.2 Actavis Business Overview
  88. 8.15.3 Actavis Topical Analgesics Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Actavis Topical Analgesics Product Portfolio
  90. 8.15.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Topical Analgesics Value Chain Analysis
  2. 9.1.1 Topical Analgesics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Topical Analgesics Sales Mode & Process
  6. 9.2 Topical Analgesics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Topical Analgesics Distributors
  9. 9.2.3 Topical Analgesics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst